Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Calls Foul On CSL Behring Hemophilia Drug Promo

Mar 07 2018

• By Brenda Sandburg

Related Content

Rx Promotion Citations By US FDA Plummet; UCLA Webpage Elicits Final Letter Of 2017

Jan 24 2018

Xtampza ER Warnings Can't Be Hidden Behind Table And Chairs, US FDA Tells Collegium

Feb 22 2018

FDA’s Rx Promo Citations Rise Slightly In 2016; Investigational Drug Promos Scrutinized

Jan 09 2017

Celebrex, Bextra Ads Draw Fire From FDA; Reminder Of “Reminder” Ad Rules

Jan 17 2005

Related Companies

CSL Limited

Collegium Pharmaceutical, Inc.

Pfizer Inc.

Additional Topics

United States Advertising, Marketing & Sales Regulation Blood & Coagulation Disorders BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window